menu search

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...

January 25, 2022, 8:43 am

Diamedica therapeutics to present research at international stroke conference

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical...

January 25, 2022, 8:43 am

Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...

January 25, 2022, 8:15 am

Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...

January 25, 2022, 8:15 am

Mindset pharma enters manufacturing deal with leading cdmo for next-generation psilocybin drug candidate, msp-1014

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) announced that it has entered into a pharmaceutical manufact...

January 25, 2022, 8:15 am

5 psychedelic therapeutics decisions coming in 2022

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...

January 25, 2022, 7:35 am

5 psychedelic therapeutics decisions coming in 2022

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...

January 25, 2022, 7:35 am

5 psychedelic therapeutics decisions coming in 2022

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their dru...

January 25, 2022, 7:35 am

Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program

The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...

January 25, 2022, 7:05 am

Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program

The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...

January 25, 2022, 7:05 am

Under barda contract, opiant pharma secures additional funding of $2m for opioid overdose program

The Biomedical Advanced Research and Development Authority (BARDA) will provide additional funding of up to $2.2 million to support Opiant ...

January 25, 2022, 7:05 am

J&j shares down 1.3% premarket after q4 revenue lags consensus

Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...

January 25, 2022, 6:45 am

J&j shares down 1.3% premarket after q4 revenue lags consensus

Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...

January 25, 2022, 6:45 am

J&j shares down 1.3% premarket after q4 revenue lags consensus

Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medi...

January 25, 2022, 6:45 am

Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why

Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...

January 24, 2022, 10:28 pm

Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why

Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...

January 24, 2022, 10:28 pm

Fda rescinds authorization for regeneron, eli lilly covid-19 antibody treatments: here's why

Antibody treatments made by Regeneron pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LL...

January 24, 2022, 10:28 pm

Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...

January 24, 2022, 6:45 pm

Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...

January 24, 2022, 6:45 pm

Mesoblast to participate in edison group's global healthcare “open house” virtual conference from january 25-27th, 2022

NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory ...

January 24, 2022, 6:45 pm


Search within

Pages Search Results: